<?xml version="1.0" encoding="UTF-8"?>
<p id="par0305">The published studies are from China, including a small cohort 7 in the treatment group and 3 in the control group [
 <xref rid="bib0430" ref-type="bibr">86</xref>] and a case report [
 <xref rid="bib0440" ref-type="bibr">88</xref>]. Some expect that clinical trials may be, nowadays or very soon, recruiting. The available data shows some promise in managing COVID-19 illness, especially in critically ill patients that could be treated under a compassionate-use protocol [
 <xref rid="bib0445" ref-type="bibr">89</xref>].
</p>
